Combination of melatonin and a peroxisome proliferator-activated receptor-gamma agonist induces apoptosis in a breast cancer cell line.
Korkmaz
Ahmet
A
Department of Cellular and Structural Biology, University of Texas Health Science Center, St. Mary's University, San Antonio, TX, USA. korkmaz@uthscsa.edu
Tamura
Hiroshi
H
Manchester
Lucien C
LC
Ogden
Gary B
GB
Tan
Dun-Xian
DX
Reiter
Russel J
RJ
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D045744:Cell Line, Tumor; D002839:Chromans / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008550:Melatonin / Q000008:administration & dosage / Q000494:pharmacology*; D008856:Microscopy, Fluorescence; D047495:PPAR gamma / Q000819:agonists*; D047488:Retinoid X Receptors; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000494:pharmacology*; D000077288:Troglitazone
D002839:Chromans; D047495:PPAR gamma; D047488:Retinoid X Receptors; D045162:Thiazolidinediones; D000077288:Troglitazone; D008550:Melatonin